Reference Material Production Platform
The company has established a standardized reference material production platform based on its ISO 17034 certification, enabling it to develop and produce high-quality reference materials in accordance with international standards.
Reference Material Production Platform
The company has established a standardized reference material production platform based on its ISO 17034 certification, enabling it to develop and produce high-quality reference materials in accordance with international standards.
Pharmaceutical Impurity Research Platform
Leveraging its ISO 17025 accreditation, the company has established a professional platform covering the entire workflow of impurity research and analytical testing, with systematic capabilities in impurity identification, quantification, and method development and validation.
Pharmaceutical Impurity Research Platform
Leveraging its ISO 17025 accreditation, the company has established a professional platform covering the entire workflow of impurity research and analytical testing, with systematic capabilities in impurity identification, quantification, and method development and validation.
Small Molecule Drug Synthesis Platform
The company has established a synthesis platform for innovative small-molecule pharmaceuticals and intermediates, with systematic capabilities spanning route design, process development, and scale-up production.
Small Molecule Drug Synthesis Platform
The company has established a synthesis platform for innovative small-molecule pharmaceuticals and intermediates, with systematic capabilities spanning route design, process development, and scale-up production.
ISO 17034
ISO 17025
 |
No. 3 Hanshan Road, Xuejia Town, Xinbei District, |
 |
+86-0519-88910898 |
 |
sales@xianglongpharm.com |
Call us
No. 3 Hanshan Road, Xuejia Town, Xinbei District,Changzhou, Jiangsu Province, China
+86-0519-88910898
sales@xianglongpharm.com